Herbicides for grain sorghum 1984

"Federal regulations on the use of herbicides change frequently, so stay informed on the status of label registration. To the best of our knowledge, this guidesheet conforms to laws and regulations at the time of writing."--First page.James A. Schaeffer, Harold D. Kerr, David Guethle, O. Hale Fletchall, E.J. Peters, L.E. Anderson, and Zane R. Helsel (Department of Agronomy, College of AGriculture)Revised 1/84/10

Chemical weed control in grain sorghum

"Federal regulations on the use of herbicides change frequently, so stay informed on the status of label registration. To the best of our knowledge, this guidesheet conforms to laws and regulations at the time of writing."--First page.James A. Schaeffer, Harold D. Kerr, David Guethle, O. Hale Fletchall, E.J. Peters, L.E. Anderson, and Zane R. Helsel (Department of Agronomy, College of AGriculture)Revised 1/85/10

Understanding Society Innovation Panel Wave 8: results from methodological experiments

This paper presents some preliminary findings from Wave 8 of the Innovation Panel (IP8) of Understanding Society: The UK Household Longitudinal Study. Understanding Society is a major panel survey in the UK. May 2015, the eighth wave of the Innovation Panel went into the field. IP8 used a mixed-mode design, using on-line interviews and face-to-face interviews. This paper describes the design of IP8, the experiments carried and the preliminary findings from early analysis of the data

Interferon β-1a in relapsing multiple sclerosis: four-year extension of the European IFNβ-1a Dose-C omparison Study

Background: Multiple sclerosis (MS) is a chronic disease requiring long-term monitoring of treatment. Objective: To assess the four-year clinical efficacy of intramuscular (IM) IFNb-1a in patients with relapsing MS from the European IFNb-1a Dose-C omparison Study. Methods: Patients who completed 36 months of treatment (Part 1) of the European IFNb-1a Dose-C omparison Study were given the option to continue double-blind treatment with IFNb-1a 30 mcg or 60 mcg IM once weekly (Part 2). Analyses of 48-month data were performed on sustained disability progression, relapses, and neutralizing antibody (NA b) formation. Results: O f 608/802 subjects who completed 36 months of treatment, 493 subjects continued treatment and 446 completed 48 months of treatment and follow-up. IFNb-1a 30 mcg and 60 mcg IM once weekly were equally effective for up to 48 months. There were no significant differences between doses over 48 months on any of the clinical endpoints, including rate of disability progression, cumulative percentage of patients who progressed (48 and 43, respectively), and annual relapse rates; relapses tended to decrease over 48 months. The incidence of patients who were positive for NAbs at any time during the study was low in both treatment groups. Conclusion: C ompared with 60-mcg IM IFNb-1a once weekly, a dose of 30 mcg IM IFNb-1a once weekly maintains the same clinical efficacy over four years

The velocity and mass distribution of clusters of galaxies from the CNOC1 cluster redshift survey

In the context of the CNOC1 cluster survey, redshifts were obtained for galaxies in 16 clusters. The resulting sample is ideally suited for an analysis of the internal velocity and mass distribution of clusters. Previous analyses of this dataset used the Jeans equation to model the projected velocity dispersion profile. However, the results of such an analysis always yield a strong degeneracy between the mass density profile and the velocity dispersion anisotropy profile. Here we analyze the full (R,v) dataset of galaxy positions and velocities in an attempt to break this degeneracy. We build an `ensemble cluster' from the individual clusters under the assumption that they form a homologous sequence. To interpret the data we study a one-parameter family of spherical models with different constant velocity dispersion anisotropy. The best-fit model is sought using a variety of statistics, including the overall likelihood of the dataset. Although the results of our analysis depend slightly on which statistic is used to judge the models, all statistics agree that the best-fit model is close to isotropic. This result derives primarily from the fact that the observed grand-total velocity histogram is close to Gaussian, which is not expected to be the case for a strongly anisotropic model. The best-fitting models have a mass-to-number-density ratio that is approximately independent of radius over the range constrained by the data. They also have a mass-density profile that is consistent with the dark matter halo profile advocated by Navarro, Frenk & White, in terms of both the profile shape and the characteristic scale length. This adds important new weight to the evidence that clusters do indeed follow this proposed universal mass density profile. [Abridged]Comment: 37 pages, LaTeX, with 11 PostScript figures. Accepted by the Astronomical Journal, to appear in the May 2000 issue. This replacement version contains an additional Appendix and one additional Figure with respect to the version submitted to astro-ph originall

The Grizzly, April 12, 2018

The Distance Between Us : Ursinus Welcomes Mexican-American Author Reyna Grande • Lantern Launch Celebrates All Things Creative About Ursinus • Berman Museum Opens Annual Student Exhibition • International Perspective: Easter Festivities in Prague Recall Student\u27s Childhood Celebrations • Senior Awarded Fulbright Scholarship • Students Present at Celebration of Student Achievement • Summer Looks Bright for Dr. Lori Daggar • Opinions: Ursinus Needs More Science Labs for Humanities Students; Facebook\u27s Data Scandal Reveals Need for Privacy Protection • Men\u27s Lax Maintains Optimism Amid Rocky Season • T&F Impresses in Outdoor Openerhttps://digitalcommons.ursinus.edu/grizzlynews/1644/thumbnail.jp

On the cosmological mass function theory

This paper provides, from one side, a review of the theory of the cosmological mass function from a theoretical point of view, starting from the seminal paper of Press & Shechter (1974) to the last developments (Del Popolo & Gambera (1998, 1999), Sheth & Tormen 1999 (ST), Sheth, Mo & Tormen 2001 (ST1), Jenkins et al. 2001 (J01), Shet & Tormen 2002 (ST2), Del Popolo 2002a, Yagi et al. 2004 (YNY)), and from another side some improvements on the multiplicity function models in literature. ...Comment: Astronomy Reports, in prin

Oral rehydration therapies in Senegal, Mali, and Sierra Leone: A spatial analysis of changes over time and implications for policy

Background: Oral rehydration solution (ORS) is a simple intervention that can prevent childhood deaths from severe diarrhea and dehydration. In a previous study, we mapped the use of ORS treatment subnationally and found that ORS coverage increased over time, while the use of home-made alternatives or recommended home fluids (RHF) decreased, in many countries. These patterns were particularly striking within Senegal, Mali, and Sierra Leone. It was unclear, however, whether ORS replaced RHF in these locations or if children were left untreated, and if these patterns were associated with health policy changes.Methods: We used a Bayesian geostatistical model and data from household surveys to map the percentage of children with diarrhea that received (1) any ORS, (2) only RHF, or (3) no oral rehydration treatment between 2000 and 2018. This approach allowed examination of whether RHF was replaced with ORS before and after interventions, policies, and external events that may have impacted healthcare access.Results: We found that RHF was replaced with ORS in most Sierra Leone districts, except those most impacted by the Ebola outbreak. In addition, RHF was replaced in northern but not in southern Mali, and RHF was not replaced anywhere in Senegal. In Senegal, there was no statistical evidence that a national policy promoting ORS use was associated with increases in coverage. In Sierra Leone, ORS coverage increased following a national policy change that abolished health costs for children.Conclusions: Children in parts of Mali and Senegal have been left behind during ORS scale-up. Improved messaging on effective diarrhea treatment and/or increased ORS access such as through reducing treatment costs may be needed to prevent child deaths in these areas

The serine protease hepsin mediates urinary secretion and polymerisation of Zona Pellucida domain protein uromodulin.

Uromodulin is the most abundant protein in the urine. It is exclusively produced by renal epithelial cells and it plays key roles in kidney function and disease. Uromodulin mainly exerts its function as an extracellular matrix whose assembly depends on a conserved, specific proteolytic cleavage leading to conformational activation of a Zona Pellucida (ZP) polymerisation domain. Through a comprehensive approach, including extensive characterisation of uromodulin processing in cellular models and in specific knock-out mice, we demonstrate that the membrane-bound serine protease hepsin is the enzyme responsible for the physiological cleavage of uromodulin. Our findings define a key aspect of uromodulin biology and identify the first in vivo substrate of hepsin. The identification of hepsin as the first protease involved in the release of a ZP domain protein is likely relevant for other members of this protein family, including several extracellular proteins, as egg coat proteins and inner ear tectorins

Double-beta decay of 130^{130}Te to the first 0+^{+} excited state of 130^{130}Xe with CUORICINO

The CUORICINO experiment was an array of 62 TeO$_{2}$ single-crystal bolometers with a total $^{130}$Te mass of $11.3\,$kg. The experiment finished in 2008 after more than 3 years of active operating time. Searches for both $0\nu$ and $2\nu$ double-beta decay to the first excited $0^{+}$ state in $^{130}$Xe were performed by studying different coincidence scenarios. The analysis was based on data representing a total exposure of N($^{130}$Te)$\cdot$t=$9.5\times10^{25}\,$y. No evidence for a signal was found. The resulting lower limits on the half lives are $T^{2\nu}_{1/2}(^{130} Te\rightarrow^{130} Xe^{*})>1.3\times10^{23}\,$y (90% C.L.), and $T^{0\nu}_{1/2}(^{130} Te\rightarrow^{130} Xe^{*})>9.4\times10^{23}\,$y (90% C.L.).Comment: 6 pages, 4 figure